Ortec Initiates Pre-Clinical Animal Model Study To Evaluate Fibrin Microbead Technology For Stem Cell Regeneration Of Non-Union Bone Defects

Source: Ortec International, Inc.
Posted: June 23, 2006

Summary:

Ortec International, Inc. (OTC Bulletin Board: ORTN), a company focused on advancing regenerative medicine through the development of cellular technology and advanced biomaterial products, announced that it has begun a pre-clinical study in rabbits to evaluate the capabilities of the Fibrin MB system to accomplish the full cycle of steps required to use a patient's own stem cells therapeutically to regenerate large gaps in long bone tissue.

Commentary: Hopefully this will lead to improved treatment of bone diseases and conditions.